KUKJEON PHARMACEUTICAL Co.,Ltd Logo

KUKJEON PHARMACEUTICAL Co.,Ltd

A chemical solutions provider manufacturing Active Pharmaceutical Ingredients and electronic materials.

307750 | KO

Overview

Corporate Details

ISIN(s):
KR7307750000
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 학의로 282 B동 1516호 (관양동,금강펜테리움), 안양시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

KUKJEON PHARMACEUTICAL Co., Ltd. is a chemical total solution provider specializing in the manufacture and sale of Active Pharmaceutical Ingredients (APIs) and electronic materials. With approximately 50 years of operational experience, the company has established itself as an API specialist. Its primary business involves producing and supplying raw materials for specialized medicines, including choline alfoscerates, benfothiamines, spherical sorbents, and napamostat. In addition to its pharmaceutical operations, the company develops electronic materials. Kukjeon also offers services such as molecular design and technical support, aiming to provide a comprehensive range of chemical-based products and services to its customers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 12.2 KB
2025-09-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.8 KB
2025-08-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.7 KB
2025-08-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 134.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-06 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.7 KB
2025-07-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 133.1 KB
2025-07-07 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 135.0 KB
2025-06-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 143.5 KB
2025-06-16 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.7 KB
2025-06-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 139.7 KB
2025-06-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 138.9 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-05-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 135.2 KB
2025-04-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 136.4 KB

Automate Your Workflow. Get a real-time feed of all KUKJEON PHARMACEUTICAL Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KUKJEON PHARMACEUTICAL Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KUKJEON PHARMACEUTICAL Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Enorama Pharma AB Logo
Develops & makes consumer nicotine products & medicated gums, offering private label solutions.
Sweden
ERMA
Ensysce Biosciences, Inc. Logo
Developing safer opioids with abuse-deterrent and overdose protection technology for severe pain.
United States of America
ENSC
Entera Bio Ltd. Logo
Developing oral versions of injectable drugs for osteoporosis, hypoparathyroidism, and obesity.
United States of America
ENTX
Entero Therapeutics, Inc. Logo
Develops targeted oral therapies for a range of gastrointestinal (GI) diseases.
United States of America
ENTO
Entrada Therapeutics, Inc. Logo
Developing intracellular therapeutics for rare neuromuscular diseases via its EEV™ platform.
United States of America
TRDA
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
South Korea
183490
Enzymatica AB Logo
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden
ENZY
Developing alopecia therapies, skin regeneration products, and preclinical CRO services.
South Korea
446440
EQL Pharma AB Logo
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden
EQL
Equillium, Inc. Logo
Clinical-stage biotech creating therapies for severe autoimmune and inflammatory disorders.
United States of America
EQ

Talk to a Data Expert

Have a question? We'll get back to you promptly.